日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Atezolizumab plus FOLFOX for Stage III Mismatch Repair-Deficient Colon Cancer

阿特珠单抗联合FOLFOX方案治疗III期错配修复缺陷型结肠癌

Sinicrope, Frank A; Ou, Fang-Shu; Arnold, Dirk; Peters, Walter R; Behrens, Robert J; Lieu, Christopher H; Matin, Khalid; Cohen, Deirdre J; Potter, Samara L; Nixon, Andrew B; Kottschade, Lisa A; Kathol, Emily; Frankel, Wendy L; Shergill, Ardaman; Hsu, Dennis; Reinacher-Schick, Anke; Mehan, Paul; Gold, Philip J; Khalil, Maged F; Zemla, Tyler; Gatten, Clare; O'Reilly, Eileen M; Meyerhardt, Jeffrey A

NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal Canal

NCI9673(B部分):ETCTN随机II期研究,评估纳武利尤单抗联合或不联合伊匹木单抗治疗难治性转移性肛管鳞状细胞癌的疗效

Morris, Van K; Ciombor, Kristen K; Xiao, Lianchun; Ochieng, Joshua K; Marmonti, Enrica; Polite, Blase; Weinberg, Benjamin A; Krauss, John C; Hays, John; Mukherjee, Sarbajit; Aranha, Olivia; Iqbal, Syma; Shields, Tony; Benson, Al B; Kazmi, Syed; Lieu, Christopher; Hochster, Howard; Whisenant, Jennifer; Haymaker, Cara; Eng, Cathy

Ensuring the Future of Cooperative Group Cancer Clinical Trials: A Call for Comprehensive Support and Prioritization

确保合作组癌症临床试验的未来:呼吁全面支持和优先考虑

Lieu, Christopher H; Sanoff, Hanna K

Efficacy of an XPO1 inhibitor in combination with irinotecan in a preclinical colorectal cancer model

XPO1抑制剂联合伊立替康在临床前结直肠癌模型中的疗效

Lentz, Robert W; Dominguez, Adrian T A; Balmaceda, Nicole Baranda; Arcaroli, John J; Bagby, Stacey M; Binns, Cameron A; Smoots, Stephen G; Jackson, Marilyn M; Macbeth, Morgan; Holmstoen, Tessa; Banerjee, Tapahsama; Whitty, Phaedra A; Yi, S Stephen; Lieu, Christopher H; Messersmith, Wells A; Pitts, Todd M

Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group

将循环肿瘤DNA检测纳入临床试验:美国国家癌症研究所胃肠肿瘤循环肿瘤DNA工作组的立场文件

Rajdev, Lakshmi; King, Gentry G; Lieu, Christopher H; Cohen, Stacey A; Pant, Shubham; Uboha, Nataliya V; Deming, Dustin; Malla, Midhun; Kasi, Anup; Klute, Kelsey; Spencer, Kristen R; Dasari, Arvind; Morris, Van K; Botta, Gregory; Lowy, Andrew M; O'Hara, Mark H; Eads, Jennifer; King, Daniel; Shah, Manish A; Hong, Theodore S; Parikh, Aparna; Klempner, Samuel J; Jabbour, Salma K; Chawla, Akhil; Molena, Daniela; George, Thomas J; Gibson, Michael K; Allegra, Carmen; Goodman, Karyn; Eng, Cathy; Philip, Philip A

From Early Detection To Advanced Therapies: How Circulating Tumor DNA Is Transforming the Care of Colorectal Cancer

从早期检测到先进疗法:循环肿瘤DNA如何改变结直肠癌的治疗

Yee, Elliott J; McCarter, Martin D; Vogel, Jon D; Schulick, Richard D; Lieu, Christopher; Lentz, Robert W

Risk Without Reward: Differing Patterns of Chemotherapy Use Do Not Improve Outcomes in Stage II Early-Onset Colon Cancer

风险与回报并无二致:不同的化疗方案并不能改善II期早期结肠癌的预后

Leary, Jacob B; Hu, Junxiao; Leal, Alexis; Davis, S Lindsey; Kim, Sunnie; Lentz, Robert; Friedrich, Tyler; Herter, Whitney; Messersmith, Wells A; Lieu, Christopher H

Genomic Landscapes of Early-Onset Versus Average-Onset Colorectal Cancer Populations

早发性结直肠癌患者与平均发病年龄结直肠癌患者的基因组图谱

Storandt, Michael H; Shi, Qian; Eng, Cathy; Lieu, Christopher; George, Thomas; Stoppler, Melissa C; Mauer, Elizabeth; Yilma, Binyam; Fragkogianni, Stamatina; Teslow, Emily A; Mahipal, Amit; Jin, Zhaohui

Oligometastatic pancreatic cancer: current state of management and emerging therapies

寡转移性胰腺癌:目前的治疗现状和新兴疗法

Khomiak, Andrii; Balmaceda, Nicole B; Ghaffar, Sumaya A; Lieu, Christopher H; Del Chiaro, Marco; Messersmith, Wells A; Lentz, Robert W

A First-In-Human Dose-Escalation Phase I Study of Basroparib, a Tankyrase Inhibitor, in Patients with Advanced-Stage Solid Tumors

一项针对晚期实体瘤患者的Tankyrase抑制剂Basroparib的首次人体剂量递增I期研究

Lieu, Christopher H; Lenz, Heinz-Josef; Benson, Al B; Meng, Xue; Kim, Uk-Il; Kim, Song Hyun; Kim, Kyungjin; Sung, Moo Je